Vir Biotechnology reports early data on T cell engagers VIR-5818 and VIR-5500, licensed from Sanofi, showing tumor shrinkage ...

Galapagos is looking for a fresh start after a rough few years. The Belgian biotech has outlined plans to branch off into two ...

A private startup looking to bring an old schizophrenia drug class to the US has released new Phase 2 data and aims to start ...

Jasper Therapeutics continued building out the data for a drug designed to treat irritable skin conditions, though the latest ...